loading . . . Pharmalittle: We're reading about FDA disarray, microdosing GLP-1 weight loss drugs, and more Observers characterized the dismissals, policy reversals, and controversies at the FDA as a soap opera, total disarray, and potentially, unprincipled https://statnews.com/pharmalot/2025/11/04/fda-tidmarsh-makary-lilly-novo-weight-obesity/